Alynni (Alectinib) 150mg Capsules 56-Pack | TLPH Laos Generic Alecensa | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Alynni (Alectinib) — Laos

Alynni is the alectinib capsule of Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. — TLPH, the Vientiane manufacturer whose motto «Make Life Better» sits on the pack — registered in Laos under No. 08L 0811/19 and packed as 56 hard capsules of 150 mg per bottle. Laos has become a serious manufacturing hub for oncology generics, and TLPH is one of its best-known names across Chinese-speaking patient networks, where Alynni circulates as a house-hold reference for affordable ALK therapy.

What Is Alynni (Alectinib) Used For?

The registered core indication is ALK-positive metastatic non-small cell lung cancer — first-line and after crizotinib — as TLPH's own product literature states. Oncologists across Southeast Asia use alectinib this way: confirm the ALK rearrangement with a validated test, start 600 mg twice daily with food, and monitor the brain with particular care because this disease favors the skull. Buyers from neighboring countries ask GLT for Alynni when originator pricing closes the door and they need the same molecule from a documented regional factory.

How Does Alynni (Alectinib) Work?

Alectinib disables the ALK fusion protein — the permanently-on growth switch that gene rearrangement creates — while retaining activity against several crizotinib-resistance mutations and against RET kinase as a laboratory target. Its two decisive pharmacologic traits: it slips past the blood-brain barrier's efflux pumps (P-gp/BCRP), accumulating in brain tissue where ALK-positive disease loves to spread, and its M4 metabolite is nearly as potent as the parent, so the blockade runs in stereo. Half-lives around thirty hours make twice-daily dosing stable and forgiving of small timing slips.

Indications of Alynni

Per the TLPH insert: ALK-positive metastatic NSCLC. Global reference labels extend use to the adjuvant setting after resection of larger or node-positive tumors, which regional oncologists cite as international practice. Every use stands on the same precondition — a documented ALK-positive test — and Alynni's literature makes the same demand before therapy begins.

Dosage and Administration

The schedule is 600 mg orally twice daily with food — four 150 mg capsules in the morning, four in the evening — so a 56-capsule bottle is a seven-day unit and most monthly orders are five bottles. Child-Pugh C liver impairment begins at 450 mg twice daily; toxicity-driven reductions step 450 → 300 mg twice daily, and intolerance of the lowest step ends therapy. Swallow capsules whole; catch up a missed dose only if six hours or more remain before the next; never re-dose after vomiting. Grapefruit products stay off the menu throughout treatment.

Side Effects of Alynni

The common line-up — constipation, swelling, muscle aches, fatigue, anemia, skin reactions — is familiar to every oncology nurse in the region, and so is the serious-watch list: liver-enzyme elevations, interstitial lung disease, slow heart rate, CPK rises with muscle injury, hemolytic anemia, and harm to a developing pregnancy. The protective rhythm is simple and cheap: liver panel and CPK every two weeks through the early months, pulse and blood pressure at every visit, immediate imaging for new breathlessness, and disciplined sun protection because photosensitivity arrives fast.

Storage Instructions

Keep the bottle below 30°C, dry, out of direct light, cap closed with the desiccant inside. No refrigeration needed. Store out of children's reach, and take expired capsules to a pharmacy rather than discarding them at home.

Why Choose Alynni from GLT?

Three practical reasons Alynni moves steadily through GLT: TLPH is a factory GLT knows and can document (registration number printed on the pack, batch records on request); the 56-capsule bottle granularity lets families buy exactly what the month needs; and the price lands typically around 70%–80% below US list pricing for the same therapy. GLT checks batch and expiry before dispatch, supports single-bottle family orders and carton-level institutional tenders alike, and answers every message personally — WhatsApp +86 15234153837, [email protected] — with same-day quotations the norm.

How to Order Alynni (Alectinib)

Enquire with product and quantity, receive a formal quotation with courier and payment options, confirm, and GLT ships with complete export documentation. Institutional buyers can request CoA and batch photographs before payment. The fast lines are WhatsApp +86 15234153837 and [email protected] — both checked daily, and standing monthly schedules are welcome.

FAQ

Who makes Alynni? Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Vientiane, Laos — registration No. 08L 0811/19 is printed on the pack.

Is Alynni the same strength as Alecensa? Yes — 150 mg capsules at the same twice-daily schedule; only the factory and the price differ.

How many bottles per month? The daily schedule is eight capsules, a bottle holds 56 — one week — so five bottles cover a month with a small buffer.

Can GLT quote Alynni next to other alectinib generics? Yes — Alecnib (Bangladesh), LuciAle and Ailedx (Laos) and the Roche originator packs are all quotable side by side.

What documents come with a shipment? Batch details and the standard export set; CoA copies for institutions on request.

Related Oncology Products

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management

Palutini (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Trans Continental Life Science & Pharmaceuticals (TLPH) (Laos) — an...

Avabopa (Avatrombopag) 20mg*30 Tablets | Tongmeng TLPH Laos | GLT

Avabopa — avatrombopag 20mg by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Lao Reg....

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...